Drug-Induced Bradycardia:When Is a Pacemaker Warranted?
Pacing and drug therapy may interact in cardiac patients in several ways, and one of them is when drug therapy induces bradycardia necessitating antibradycardia pacing. In this paper, several aspects of drug-induced bradycardia (DIB) will be discussed: definition, epidemiology, physiology, pathogenesis, drugs leading to bradycardia, clinical settings when DIB can require pacing, and management of DIB.
KeywordsCoronary Flow Drug Discontinuation Chronotropic Incompetence Onset Atrial Fibrillation Symptomatic Bradycardia
Unable to display preview. Download preview PDF.
- 2.Israel CW, Ehrlich JR., Barold SS et al (2002) Treatment of tachyarrhythmias with pacing and antiarrhythmic drugs. In: Israel CW, Barold SS (eds) Advances in the treatment of atrial tachyarrhythmias: pacing, cardioversion, and defibrillation. Futura, Armonk, NY, pp 305–323Google Scholar
- 4.Reynolds MR, Hadjis T, Schwartzman DS et al (2003) Age and amiodarone use are important determinants of the need for permanent pacing among new onset AF patients (abstract). Pacing Clin Electrophysiol 26:1016, A350Google Scholar